Application Nr Approved Date Route Status External Links
NDA207987 None Percutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Ablysinol ® Is Indicated To Induce Controlled Cardiac Septal Infarction To Improve Exercise Capacity In Adults With Symptomatic Hypertrophic Obstructive Cardiomyopathy Who Are Not Candidates For Surgical Myectomy. Ablysinol Is An Ablative Agent Indicated To Induce Controlled Cardiac Septal Infarction To Improve Exercise Capacity In Adults With Symptomatic Hypertrophic Obstructive Cardiomyopathy Who Are Not Candidates For Surgical Myectomy. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Alcohol

Comments